Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Right Value Drug Stores, LLC dba Carie Boyd Pharmaceuticals
WARNING LETTER
•Right Value Drug Stores, LLC dba Carie Boyd Pharmaceuticals•June 21, 2024

Right Value Drug Stores, LLC dba Carie Boyd Pharmaceuticals – FDA Warning Letter, Jun 21, 2024

Record Details

On December 17, 2024, the FDA issued Warning Letter WL #694687 to Right Value Drug Stores, LLC dba Carie Boyd Pharmaceuticals, an outsourcing facility registered under section 503B of the FDCA. The letter followed an inspection from May 28 to June 21, 2024, which revealed significant deficiencies.

The facility failed to meet 503B conditions, specifically by not including the quantity or proportion of inactive ingredients on labels for products like Ketoconazole 2% Cream and Testosterone Cypionate injections. This renders their compounded drugs ineligible for exemptions from FDA approval, adequate directions for use labeling, and Drug Supply Chain Security Act requirements.

The FDA also identified adulterated drug products due to insanitary conditions and CGMP violations. Insanitary conditions included inadequate smoke studies showing disrupted unidirectional airflow in the ISO 5 area and media fills not performed under challenging conditions. CGMP violations cited failure to follow procedures to prevent microbiological contamination (21 CFR 211.113(b)), inadequate investigation of discrepancies (21 CFR 211.192), improper cleaning/sterilization of container closures (21 CFR 211.94(c)), inadequate equipment cleaning/maintenance procedures (21 CFR 211.67(b)), and insufficient environmental controls (21 CFR 211.46(b)).

Company
Right Value Drug Stores, LLC dba Carie Boyd Pharmaceuticals
Inspection date
June 21, 2024
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • F. Gail Bormel (F.)
View Company Profile

ID · 4626610d-8a07-4cfa-b70c-ee56f329331c

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 353b21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 360eee-121 U.S.C. 353b(d)(4)21 U.S.C. 351(a)(2)(A)21 U.S.C. 353b(a)(10)21 U.S.C. 331(k)21 CFR 211.113(b)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Right Value Drug Stores, LLC dba Carie Boyd Pharmaceuticals
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.